Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
Conditions: Uveal Melanoma; Metastatic Cancer Interventions: Drug: Cediranib Maleate; Drug: Durvalumab Sponsors: Grupo Español Multidisciplinar de Melanoma; MFAR Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Eye Cancers | Melanoma | Research | Skin Cancer | Uveal Melanoma